A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor.
暂无分享，去创建一个
M. Namer | J. Bonneterre | J. Zalcberg | I. Smith | N. Wilking | M. Spielmann | T. Hatschek | M. Green | J. Spiers | A. Jones | H. Wander | L. Seymour | John R. Zalcberg | Jacques Bonneterre | Nils Wilking | Marc Spielmann | Moïse Namer | Ian E. Smith | Green | HE Wander | Leonard W. Seymour